IMPACT. MAKE ONE.

Help us prevent the preventable, treat the treatable, and put an end to breast cancer forever.

Request a Speaker or Educational Materials!

Advocates in Science Training More

EARLY SUSAN G. KOMEN FOR THE CURE® RESEARCH FUNDING LEADS TO NEW DIAGNOSTIC TOOL FOR CANCER’S SPREAD More

Susan G. Komen for the Cure® Hails FDA Approval of Treatment for Aggressive Form of Breast Cancer More

2013 Race for the Cure

Join us this year on October 12th, 2013 for the 22nd annual Race for the Cure!

Get Involved with our Affiliate in the Community

View our Calender of Events!

Is ductal carcinoma in situ (DCIS) breast cancer?
Ductal carcinoma in situ (DCIS) is breast cancer, but it is non-invasive. About 55,000 new cases of DCIS are expected to be diagnosed among women in the U.S. in 2013. Learn more now.

How Komen's research investment has changed the breast cancer landscape
As we've come to understand more about the biology of breast cancer, Komen's research agenda has changed tremendously over the past 10-15 years. Read more about Komen's research investment.